Litcius/Paper detail

The Role of Oncotype DX® Recurrence Score in Predicting Axillary Response After Neoadjuvant Chemotherapy in Breast Cancer

Jaime Pardo, Betty Fan, Alessandra Mele, Stephanie K. Serres, Monica G. Valero, Isha Emhoff, Amulya Alapati, Ted A. James

2021Annals of Surgical Oncology24 citationsDOI

Topics & Concepts

MedicineBreast cancerInternal medicineOncologySurgical oncologyChemotherapyEstrogen receptorStage (stratigraphy)MastectomyCancerGynecologyBiologyPaleontologyBreast Cancer Treatment StudiesBreast Lesions and CarcinomasBreast Implant and Reconstruction
The Role of Oncotype DX® Recurrence Score in Predicting Axillary Response After Neoadjuvant Chemotherapy in Breast Cancer | Litcius